Filing Details

Accession Number:
0001735276-25-000062
Form Type:
4
Zero Holdings:
No
Publication Time:
2025-05-12 16:05:00
Reporting Period:
2024-08-29
Filing Date:
2025-05-12
Accepted Time:
2025-05-12 16:05:00
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1178670 Alnylam Pharmaceuticals Inc. ALNY Pharmaceutical Preparations (2834) 770602661
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1740730 F Colleen Reitan 675 West Kendall Street
Henri A. Termeer Square
Cambridge MA 02142
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2024-08-29 32 $286.00 32 No 4 P Direct
Common Stock Acquisiton 2024-10-17 4 $302.67 36 No 4 P Direct
Common Stock Disposition 2025-04-16 36 $232.86 0 No 4 S Direct
Common Stock Acquisiton 2025-05-08 775 $0.00 775 No 4 A Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
No 4 S Direct
No 4 A Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Acquisiton 2025-05-08 1,558 $0.00 1,558 $258.35
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
1,558 2026-05-08 2035-05-08 No 4 A Direct
Footnotes
  1. These shares are represented by restricted stock units (RSUs) granted under the Amended and Restated 2018 Stock Incentive Plan. Each RSU represents a contingent right to receive one share of common stock. The RSUs will vest in full upon the earlier of the first anniversary of the grant date and the date of any earlier retirement or resignation of the Reporting Person, provided such date of retirement or resignation occurs no more than 90 days prior to the first anniversary of the grant date.
  2. The stock option vests in full upon the earlier of the first anniversary of the grant date and the date of any earlier retirement or resignation of the Reporting Person, provided such date of retirement or resignation occurs no more than 90 days prior to the first anniversary of the grant date.